Which monoclonal anti-TNF biologic agent is indicated for induction and maintenance of remission in severe fistulizing Crohn's disease?
সমাধান
সঠিক উত্তর: Option B
Infliximab is a monoclonal anti-TNF antibody indicated for remission in fistulizing Crohn's disease .
- Adalimumab / Certolizumab: Used in Crohn's, but Infliximab is key for fistulae .
- Golimumab: Indicated in ulcerative colitis .
BCS High Yield Points
- Infliximab is given by IV infusion .
- Screen for latent TB before anti-TNF therapy .
- Certolizumab is safe in pregnancy .
Source: Davidson's Principles and Practice of Medicine
- Adalimumab / Certolizumab: Used in Crohn's, but Infliximab is key for fistulae .
- Golimumab: Indicated in ulcerative colitis .
BCS High Yield Points
- Infliximab is given by IV infusion .
- Screen for latent TB before anti-TNF therapy .
- Certolizumab is safe in pregnancy .
Source: Davidson's Principles and Practice of Medicine